Matteo Carminati
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Real-world effectiveness and tolerability of desvenlafaxine in major depressive disorder: A multicentre prospective Italian national-cohort study.
Journal: Psychiatry research
Published: May 01, 2026
Fast-acting approaches for treatment-resistant depression: real-world comparative effectiveness of Intranasal Esketamine versus accelerated rTMS.
Journal: International journal of psychiatry in clinical practice
Published: March 12, 2026
Higher Neutrophil-to-Lymphocyte Ratio Is Associated With Better Response to Esketamine in Treatment-Resistant Depression: A Post Hoc Exploratory Analysis of Real-World Data.
Journal: Journal of clinical psychopharmacology
Published: January 25, 2026
Synergistic Effect of Passiflora incarnata L., Herba and Cognitive Behavioural Therapy in the Management of Benzodiazepine Misuse.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 17, 2025
Defining treatment-resistant depression in a real-world setting: impact of a staging model on clinical features and treatment trajectories.
Journal: International clinical psychopharmacology
Published: December 10, 2025
Insulin Resistance and Leptin Dysregulation Impact In Vivo Brain Structure and Cognitive Functioning in Mood Disorders: A Multimodal Partial Least Squares Path Modeling Study.
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: September 19, 2025
Intravenous Ketamine Followed by Intranasal Esketamine in 2 Subsequent Treatment-resistant Depressive Episodes: Insights From a Case Series.
Journal: Journal of psychiatric practice
Published: September 15, 2025
Biotypes of deeply phenotyped depressed patients reflect signatures of adverse childhood experience and depressive cognitive biases.
Journal: Journal of affective disorders
Published: July 25, 2025
Glucagon-like peptide-1 receptor agonist semaglutide through the lens of psychiatry: a systematic review of potential benefits and risks.
Journal: International clinical psychopharmacology
Published: June 27, 2025
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
Journal: Journal of personalized medicine
Published: March 06, 2025
Last Updated: 09/26/2026